ecancermedicalscience

Conference Report

Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials

8 Dec 2014
Linda Cairns

Chemoprevention or the now more preferred ‘cancer prevention’ is the long-term administration of a biological or chemical agent to reduce the risk of cancer. This approach has long been active in individuals at high risk of developing breast or colon cancer. The aim of this expert meeting was to review the current status of the field of cancer prevention and potential, emerging biomarkers specifically focusing on breast, colon, and lung cancer but also with sessions on ovary and prostate.

Related Articles

Jorge Hoegl, Andreina Fernandes, Fernando Hidalgo, Sunangela Escalona, Anthony López, Yetsy Muñoz, Paola Morillo, Mary Carmen Hidalgo, Luisa López, María Briceño, María Mercedes Pérez
José Darío Portillo-Miño, John Jairo Calderon, David Bettin Gonzalez, Yeison Carlosama, Lorena Lagarde, Rafael Parra-Medina
Saquib Zaffar Banday, Malik Tariq Rasool, Sheikh Zahoor Ahmad, Lekshmi Shenoy, Aaqib Zaffar Banday, Maniza Ayub, Bishal Gyawali
Chinaecherem P Okafor, Chekwube K Nwufo, Victor Akachukwu Ibiam